![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Padberg B.-C. Rordorf T. Suter S. Pfeiffer D. Wild D. Schröder S.
Publisher: Springer Publishing Company
ISSN: 0172-8113
Source: Der Pathologe, Vol.28, Iss.4, 2007-07, pp. : 281-284
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Upfront treatment of high‐risk neuroblastoma with a combination of 131I‐MIBG and Topotecan
PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 1545-5009, Iss. 11, 2015-11 ,pp. :